Department of Internal Medicine, American University of Beirut, Lebanon
Volume 35, Issue 1, March 2024
Sign in to download the Issue in PDF format.
1155152505
Mediterr J Rheumatol 2020;31(3):362-5
Article Links
Acute Coronary Syndrome in a Male with Elevated Anti-Cyclic Citrullinated Peptide and no Evidence of Longstanding Rheumatoid Arthritis
References
- Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012 Sep;71(9):1524-9.
- del Val del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clin Exp Rheumatol 2006 Jun;24(3):281-6.
- Sokolove J, Brennan MJ, Sharpe O, Lahey LJ, Kao AH, Krishnan E, et al. Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis. Arthritis Rheum 2013 Jul;65(7):1719-24.
- Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B, BARFOT Study Group. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 2004 Sep;63(9):1090-5.
- Arnab B, Biswadip G, Arindam P, Shyamash M, Anirban G, Rajan P. Anti-CCP antibody in patients with established rheumatoid arthritis: Does it predict adverse cardiovascular profile? J Cardiovasc Dis Res 2013 Jun;4(2):102-6.
- Cambridge G, Acharya J, Cooper JA, Edwards JC, Humphries SE. Antibodies to citrullinated peptides and risk of coronary heart disease. Atherosclerosis 2013 May 1;228(1):243-6.
- Elevated Anti-Cyclic Citrullinated Peptide Antibody Titer Is Associated with Increased Cardiovascular Risk [Internet]. ACR Meeting Abstracts. [cited 2020 Feb 15]. Available from: https://acrabstracts.org/abstract/elevated-anti-cyclic-citrullinated-peptide-antibody-titer-is-associated-with-increased-cardiovascular-risk/
- Fantus SA, Heisler A, Briones MR, Martin B, Correia C, Ostrowski RA. Association of Elevated Anti-Cyclic Citrullinated Peptide Antibody Titer with Increased Cardiovascular Risk. J Rheumatol Arthritis Res (1):6.
- Hermans MPJ, van der Velden D, Montero Cabezas JM, Putter H, Huizinga TWJ, Kuiper J, et al. Long-term mortality in patients with ST-segment elevation myocardial infarction is associated with anti-citrullinated protein antibodies. Int J Cardiol 2017 Aug 1;240:20-4.
- Innala L, Möller B, Ljung L, Magnusson S, Smedby T, Södergren A, et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 2011;13(4):R131.